作者
Veysel Gök,Göksel Leblebisatan,Dilek Gürlek Gökçebay,Salih Güler,Muhammet Ensar Doğan,Sevcan Tuğ Bozdoğan,Ayça Koca Yozgat,Alper Özcan,Esra Pekpak Şahinoğlu,Hüseyin Tokgöz,Metin Çil,Şebnem Özemri Sağ,Ebru Yılmaz,Hatice Şaşmaz,Melike Sezgin Evim,Sinan Akbayram,Meriban Karadoğan,Fatma Türkan Mutlu,İbrahim Boğa,Burcu Yeter,Neşe Yaralı,Ümran Çalışkan,Atıl Bişgin,Şehime Gülsün Temel,Melanie Proven,Kate Gibson,Büşra Şeniz Demir,Hatice Saraçoğlu,Ahmet Eken,Çiğdem Karakükçü,Musa Karakükçü,Adalet Meral Güneş,Namık Özbek,Yurdanur Kılınç,Türkan Patıroğlu,Mehmet Âkif Özdemir,Noémi Roy,Ekrem Ünal
摘要
Summary Pyruvate kinase (PK) is a key enzyme of anaerobic glycolysis. The genetic heterogeneity of PK deficiency (PKD) is high, and over 400 unique variants have been identified. Twenty‐nine patients who had been diagnosed as PKD genetically in seven distinct paediatric haematology departments were evaluated. Fifteen of 23 patients (65.2%) had low PK levels. The PK:hexokinase ratio had 100% sensitivity for PKD diagnosis, superior to PK enzyme assay. Two novel intronic variants (c.695‐1G>A and c.694+43C>T) have been described. PKD should be suspected in patients with chronic non‐spherocytic haemolytic anaemia, even if enzyme levels are falsely normal. Total PKLR gene sequencing is necessary for the characterization of patients with PKD and for genetic counselling.